Definium Therapeutics (DFTX) Tax Rate (2021 - 2022)
Definium Therapeutics' (DFTX) quarterly Tax Rate came in at 4.57% in Q4 2022, up 6983.0% year-on-year from 0.06% in Q4 2021, and up 93.86% on a QoQ basis from 74.4% in Q4 2021.
Definium Therapeutics (DFTX) Tax Rate (2021 - 2022) Analysis & Trends
Definium Therapeutics (DFTX) has 2 years of Tax Rate data on file, last reported at 4.57% in Q4 2022.
- On a quarterly basis, Tax Rate rose 6983.0% year-over-year to 4.57% in Q4 2022; TTM through Dec 2022 was 29.48%, a N/A change from a year earlier, with the FY2022 full-year figure at 0.39%, down 4026.0% from the prior year.
- Tax Rate for Q4 2022 stood at 4.57%, up from 74.4% in the prior quarter.
- Over the last five years, Tax Rate for DFTX reached as high as 4.57% in Q4 2022 and fell as low as 74.4% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -4.57% |
| Dec 31, 2022 | -4.57% |
| Dec 31, 2022 | -4.57% |
| Dec 31, 2021 | -74.40% |
| Dec 31, 2021 | -74.40% |
| Dec 31, 2021 | -74.40% |